Drug or treatment
Carilizumab clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Carilizumab that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Camrelizumab plus albumin-bound paclitaxel as second-line treatment for advanced stomach cancer
We will try camrelizumab combined with albumin-bound paclitaxel to see if it helps people with advanced stomach cancer whose disease progressed after first-line treatment, including those who did or did not receive prior immunotherapy.
-
Combining Carilizumab and Apatinib for Advanced Gastric Cancer
This study is testing if combining two medications, Carilizumab and Apatinib, can help people with advanced gastric cancer live longer without their disease getting worse.
Quick answers
How many clinical trials of Carilizumab are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.